About SafePulse | Public Health & Harm Reduction

To protect and preserve public health and relieve physical and mental distress among individuals using or affected by image- and performance-enhancing drugs and substances.

We aim to achieve this through four core areas of activity.

Why we started

Accessible information.
Specialist support.

Our Commitment to Public Health

Our work focuses on the physical and mental health challenges associated with substances including anabolic steroids, peptides, and emerging performance-enhancing compounds.

We recognise the growing need for accessible, evidence-based information and specialist support for individuals who use IPEDs, those affected by their use, and the professionals working with them.

Our approach is rooted in public health, scientific evidence, confidentiality, and non-judgemental engagement.

We aim to reduce preventable harm, improve access to healthcare, advance professional understanding, and contribute to research that informs public health practice and policy.

We believe that everyone deserves access to accurate health information, appropriate healthcare, and respectful, non-judgemental support.

Our organisation is committed to:

Illustrative peaceful green space with an accessible walking path and bench.

Protecting Public Health

Reducing preventable harm and supporting physical and mental wellbeing.

Illustrative research papers, reference books and reading glasses on a desk.

Evidence-Based Practice

Ensuring our information, education, and services are informed by credible scientific evidence.

Illustrative private, welcoming conversation space with two chairs and frosted glass.

Confidentiality & Respect

Creating an environment where individuals can seek support without fear of stigma or discrimination.

Illustrative open book and learning materials in a quiet study space.

Education & Prevention

Improving knowledge among individuals, professionals, and communities.

Illustrative close-up of microscope lenses and a glass slide on a research bench.

Research & Innovation

Advancing understanding of emerging substances and their implications for public health.

Illustrative round community meeting table with notebooks and chairs.

Collaboration & Community Benefit

Working with healthcare services, researchers, professional organisations, and communities to achieve meaningful public benefit.

Our educational work does not promote or encourage substance use or replace individual medical advice. Harm reduction does not mean that substance use can be made risk-free.

Our focus

Four areas, one mission.

Illustrative consultation space with a blood pressure monitor.

Community Health & Clinical Support

Improving access to healthcare and specialist support.

We aim to develop a dedicated community health hub providing a safe, confidential, and non-judgemental environment for individuals seeking information, health advice, and support relating to IPED use.

Activities & objectives

Our planned activities include:

Confidential health advice and specialist guidance.
Appropriate health screening and physiological monitoring.
Support for physical and psychological wellbeing.
Early identification of potential health concerns.
Harm-reduction education and preventative healthcare.
Signposting and referral to NHS services and other appropriate healthcare providers.

Our objective is to improve access to appropriate healthcare, reduce preventable health complications, and support better long-term health outcomes.

Illustrative laptop workspace for accessing health information.

Digital Health Information & Support

Making reliable information accessible to everyone.

We aim to develop digital platforms and educational resources that improve public understanding of IPEDs and their potential health implications.

Activities & objectives

Our work will include:

Evidence-based information about anabolic steroids, peptides, and emerging substances.
Public health updates on changing substance-use trends.
Information about potential physical and psychological health consequences.
Digital education and harm-reduction resources.
Online support networks and community engagement.
Guidance on accessing appropriate healthcare services.

Our objective is to address misinformation, improve health literacy, and ensure individuals and professionals have access to accurate and independent information.

Illustrative workshop space prepared for shared learning.

Education & Professional Development

Supporting informed practice across healthcare, fitness, and public health.

We aim to provide specialist education and professional development opportunities to improve awareness and understanding of IPED-related health issues.

Activities & objectives

Our activities will include:

Training for healthcare professionals.
Educational workshops for fitness professionals and personal trainers.
Seminars for public health organisations.
Specialist information for government agencies and policymakers.
Community education and awareness initiatives.
Evidence-based educational materials and professional resources.

Our objective is to strengthen professional knowledge, reduce stigma, improve early identification of health concerns, and support effective engagement with individuals affected by IPED use.

Illustrative microscope and notebook on a research bench.

Research & Public Health Evidence

Improving understanding through research and collaboration.

We aim to conduct, commission, support, and publish research examining the use, health impacts, and evolving trends associated with IPEDs.

Activities & objectives

Our research priorities include:

The physical and psychological impacts of IPED use.
Emerging peptides and performance-enhancing substances.
Patterns of use and changing public health trends.
Barriers to accessing healthcare and support.
Harm-reduction approaches and preventative interventions.
Evidence-based recommendations for healthcare practice and public health policy.

We seek to collaborate with universities, healthcare providers, researchers, and public health organisations to strengthen the evidence base and support effective public health responses.

Our objective is to contribute to scientific understanding, inform professional practice, and improve health outcomes.

Our Vision

A society in which individuals affected by image- and performance-enhancing drug use can access appropriate healthcare, reliable information, and non-judgemental support, while professionals and public health organisations have the evidence and knowledge needed to respond effectively.

Through education, research, community engagement, and accessible health services, we aim to improve public health outcomes and reduce the harms associated with IPED use.

Our Legal Status

We currently operate as a Community Interest Company (CIC), established to deliver activities for the benefit of the community.

We are pursuing charitable status to support the development and expansion of our public health, education, research, and community support activities.

Our work is focused on delivering measurable public benefit through improved health awareness, access to support, professional education, and scientific research

Our purpose

Proposed charitable purpose

Our proposed purpose for registration as a Charitable Incorporated Organisation (CIO).

To protect and preserve public health, and to relieve sickness, physical and mental distress amongst individuals using or affected by image- and performance-enhancing drugs (IPEDs) and substances (including but not limited to anabolic steroids, peptides, and associated image-enhancing compounds), in particular, but not exclusively by:

(a)
Operating a physical office and community hub to provide confidential clinical advice, health screening, physiological monitoring, and signposting to health services;
(b)
Developing and maintaining digital platforms, online support networks, and evidence-based information resources highlighting emerging substances and trends;
(c)
Providing specialised training, workshops, seminars, and educational resources to fitness professionals, healthcare providers, government organisations, and the wider public; and
(d)
Conducting, commissioning, and publishing evidence-based research into the use, health impacts, and evolving trends of IPEDs, peptides and new substances involved in performance enhancement.